These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differences in the immunogenicity of the HL-A antigens. Minev M Vox Sang; 1975; 29(6):433-9. PubMed ID: 1210227 [TBL] [Abstract][Full Text] [Related]
7. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis. Bertrams HJ; Kuwert EK J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587 [TBL] [Abstract][Full Text] [Related]
8. HL-A antigens and multiple sclerosis. Jersild C; Svejgaard A; Fog T Lancet; 1972 Jun; 1(7762):1240-1. PubMed ID: 4113225 [No Abstract] [Full Text] [Related]
9. [Study of 39 cases of multiple sclerosis (MS) including 2 familial cases. Leukocyte migration inhibition test in the presence of measles antigen with and without levamisole. HL-A typing (SD)]. Hainaut J; Ribot C; Lefebvre P; Goasguen J; Piette JP Ann Med Interne (Paris); 1977 Oct; 128(10):767-72. PubMed ID: 931233 [No Abstract] [Full Text] [Related]
10. Histocompatibility (HL-A) antigens associated with multiple sclerosis. Jersild C; Fog T Acta Neurol Scand Suppl; 1972; 51():377. PubMed ID: 4514355 [No Abstract] [Full Text] [Related]
11. Multiple sclerosis: association with HL-A3. Naito S; Namerow N; Mickey MR; Terasaki PI Tissue Antigens; 1972; 2(1):1-4. PubMed ID: 5077731 [No Abstract] [Full Text] [Related]
13. [The biological implications of the main histocompatibility system: the HL-A system]. Dausset J C R Seances Soc Biol Fil; 1974; 168(2-3):160-72. PubMed ID: 4282269 [No Abstract] [Full Text] [Related]